bendamustine

Ukraine

Drugs containing this active substance

  • BENDAMUSTINE AXIOS

    The drug is used for the therapy of chronic lymphocytic leukemia, indolent non-Hodgkin lymphomas, as well as multiple myeloma (in patients aged 65 and older who are not candidates for stem cell transplantation).

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    bendamustine 25 mg or 100 mg

    ATC: L01AA09

    Manufacturer: AxioNovo GmbH (secondary packaging; batch release)

  • BENDAMUSTINE HYDROCHLORIDE FOR INJECTION

    The drug is prescribed for the treatment of patients with chronic lymphocytic leukemia (CLL), as well as for the treatment of indolent B-cell non-Hodgkin lymphoma (NHL) in cases of disease progression during or 6 months after rituximab therapy.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    bendamustine 25 mg

    ATC: L01AA09

    Manufacturer: Eugia Pharma Specialities Limited

  • BENDAMUSTINE HYDROCHLORIDE FOR INJECTION

    The drug is intended for the treatment of patients with chronic lymphocytic leukemia (CLL), as well as for the treatment of indolent B-cell non-Hodgkin lymphoma (NHL) in cases of disease progression during or 6 months after rituximab therapy.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    bendamustine 100 mg

    ATC: L01AA09

    Manufacturer: Eugia Pharma Specialities Limited

  • BENDAMUSTINE-VISTA

    The drug is used for the therapy of chronic lymphocytic leukemia, indolent non-Hodgkin lymphomas, as well as multiple myeloma (in patients over 65 years of age under certain conditions).

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    bendamustine 25 mg or 100 mg

    ATC: L01AA09

    Manufacturer: Syndan Pharma S.R.L.

  • BENDAMUSVISTA

    The drug is used for the therapy of chronic lymphocytic leukemia, indolent non-Hodgkin lymphomas, as well as multiple myeloma (in combination with prednisone for patients of a certain age and condition).

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    bendamustine 25 mg

    ATC: L01AA09

    Manufacturer: Synthon s.r.o. (responsible for batch release)

  • BENDAMUSWISTA

    The drug is used for the therapy of chronic lymphocytic leukemia (first-line), indolent non-Hodgkin lymphomas (as monotherapy in case of disease progression), and multiple myeloma (in combination with prednisone for patients of a certain age and condition).

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    bendamustine 100 mg

    ATC: L01AA09

    Manufacturer: Synthon s.r.o. (responsible for batch release)

  • BENTERO

    The drug is used for the therapy of chronic lymphocytic leukemia, as well as for the treatment of advanced stages of indolent non-Hodgkin lymphomas (as part of combination therapy).

    Form: lyophilisate for solution for injection

    Active substance Dosage
    bendamustine 25 mg

    ATC: L01AA09

    Manufacturer: Hetero Labs Limited

  • BENTERO

    The drug is used for the therapy of chronic lymphocytic leukemia, as well as for the treatment of advanced stages of indolent non-Hodgkin lymphomas (as part of combination therapy).

    Form: lyophilisate for solution for injection

    Active substance Dosage
    bendamustine 100 mg

    ATC: L01AA09

    Manufacturer: Hetero Labs Limited